Aspirin for Primary Prevention of Cardiovascular Events

The efficacy and safety of aspirin for primary prevention of cardiovascular disease (CVD) remain debatable. The purpose of this study was to examine the clinical outcomes with aspirin for primary prevention of CVD after the recent publication of large trials adding >45,000 individuals to the publ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2019-06, Vol.73 (23), p.2915-2929
Hauptverfasser:	Abdelaziz, Hesham K, Saad, Marwan, Pothineni, Naga Venkata K, Megaly, Michael, Potluri, Rahul, Saleh, Mohammed, Kon, David Lai Chin, Roberts, David H, Bhatt, Deepak L, Aronow, Herbert D, Abbott, J Dawn, Mehta, Jawahar L
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Angina pectoris Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Aspirin Aspirin - administration & dosage Aspirin - adverse effects Bias Bleeding Cancer Cardiology Cardiovascular diseases Cardiovascular Diseases - diagnosis Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Cerebral infarction Clinical trials Confidence intervals Control methods Death Diabetes Diabetic retinopathy Disease prevention Gastrointestinal Hemorrhage - chemically induced Gastrointestinal Hemorrhage - diagnosis Gastrointestinal Hemorrhage - mortality Health risk assessment Humans Ischemia Mortality Myocardial infarction Prevention Primary Prevention - methods Primary Prevention - trends Randomization Randomized Controlled Trials as Topic - methods Risk Stroke Studies Transient ischemic attack Vitamin E
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!